Edap Tms (NASDAQ:EDAP) Director Joshua Levine Buys 10,000 Shares

Edap Tms S.A. (NASDAQ:EDAP) Director Joshua Levine purchased 10,000 shares of the stock in a transaction dated Monday, May 11th. The shares were purchased at an average price of $4.22 per share, with a total value of $42,200.00. Following the completion of the acquisition, the director owned 35,000 shares of the company’s stock, valued at approximately $147,700. This represents a 40.00% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Edap Tms Stock Performance

Shares of NASDAQ EDAP opened at $4.08 on Wednesday. The company has a market cap of $152.92 million, a PE ratio of -5.04 and a beta of -0.10. Edap Tms S.A. has a 12 month low of $1.21 and a 12 month high of $5.05. The company has a debt-to-equity ratio of 1.79, a current ratio of 1.34 and a quick ratio of 0.99. The company has a 50-day simple moving average of $3.70 and a 200-day simple moving average of $3.41.

Edap Tms (NASDAQ:EDAP) last issued its quarterly earnings results on Thursday, May 7th. The medical equipment provider reported ($0.24) EPS for the quarter, missing analysts’ consensus estimates of ($0.22) by ($0.02). The firm had revenue of $20.48 million for the quarter, compared to analysts’ expectations of $19.46 million. Edap Tms had a negative return on equity of 137.61% and a negative net margin of 41.47%. On average, equities analysts anticipate that Edap Tms S.A. will post -0.82 earnings per share for the current year.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in EDAP. Flax Pond Capital LLC acquired a new position in shares of Edap Tms during the fourth quarter worth $2,623,000. Leonteq Securities AG acquired a new position in shares of Edap Tms during the fourth quarter worth $313,000. Rock Springs Capital Management LP lifted its position in shares of Edap Tms by 1.3% during the fourth quarter. Rock Springs Capital Management LP now owns 1,286,500 shares of the medical equipment provider’s stock worth $4,233,000 after purchasing an additional 16,500 shares in the last quarter. Kovack Advisors Inc. acquired a new position in shares of Edap Tms during the fourth quarter worth $53,000. Finally, SmartHarvest Portfolios LLC acquired a new position in shares of Edap Tms during the first quarter worth $38,000. 62.74% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of equities research analysts have recently commented on the stock. HC Wainwright lowered their price target on shares of Edap Tms from $14.00 to $10.00 and set a “buy” rating for the company in a report on Thursday, April 9th. Wall Street Zen cut shares of Edap Tms from a “hold” rating to a “sell” rating in a research report on Saturday, March 28th. One equities research analyst has rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $6.00.

Edap Tms Company Profile

Edap Tms SA (NASDAQ: EDAP) is a Lyon, France–based medical device company that develops and markets noninvasive therapeutic systems for urological applications. The firm’s core focus lies in high-intensity focused ultrasound (HIFU) for localized prostate tissue ablation and extracorporeal shock-wave lithotripsy for kidney stone fragmentation. Edap Tms’s Ablatherm HIFU platform delivers targeted ultrasound energy to treat prostate cancer without incisions, while its Sonolith line offers pulse-focused shock waves designed to break down urinary calculi.

Since its founding in 1989, Edap Tms has pursued regulatory clearances in multiple markets, including CE marking in Europe and FDA clearance for its HIFU system in the United States.